Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.800
-0.070 (-2.44%)
At close: May 13, 2026, 4:00 PM EDT
2.850
+0.050 (1.79%)
After-hours: May 13, 2026, 6:18 PM EDT

Ovid Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.127.250.570.391.5208.38
Revenue Growth (YoY)
1199.63%1181.27%44.39%-73.91%-99.28%1551.58%
Gross Profit
7.127.250.570.391.5208.38
Selling, General & Admin
24.7524.1125.6831.0932.4337.23
Research & Development
30.1125.5836.7728.5924.6246.94
Total Operating Expenses
54.8649.6962.4559.6757.0584.17
Operating Income
-47.74-42.44-61.89-59.28-55.55124.21
Total Non-Operating Income (Expense)
23.5725.0335.456.941.38-0.05
Pretax Income
-24.17-17.41-26.43-52.34-54.17124.16
Provision for Income Taxes
-----1.33
Net Income
-24.17-17.41-26.43-52.34-54.17122.84
Net Income to Common
-24.17-17.41-26.43-52.34-54.17122.84
Shares Outstanding (Basic)
907471717067
Shares Outstanding (Diluted)
907471717068
Shares Change (YoY)
26.68%3.99%0.46%0.22%3.46%16.45%
EPS (Basic)
-0.29-0.23-0.37-0.73-0.771.78
EPS (Diluted)
-0.29-0.23-0.37-0.73-0.771.76
Shares Outstanding
167.27130.1872.2670.6970.4770.36
Free Cash Flow
-41.95-38.33-56.03-45.82-56.45118.43
Free Cash Flow Per Share
-0.47-0.52-0.79-0.65-0.801.74
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-670.25%-585.20%-10933.70%-15122.70%-3696.44%59.61%
Profit Margin
-339.31%-240.13%-4670.14%-13351.80%-3604.66%58.95%
FCF Margin
-589.06%-528.60%-9898.76%-11689.00%-3756.55%56.83%
EBITDA
-47.57-42.17-61.27-58.71-55.04124.45
EBITDA Margin
-667.90%-581.44%-10825.40%-14977.80%-3662.33%59.72%
EBIT
-47.74-42.44-61.89-59.28-55.55124.21
EBIT Margin
-670.25%-585.20%-10933.70%-15122.70%-3696.44%59.61%
Effective Tax Rate
-0.00%0.00%0.00%0.00%1.07%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q